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Abstract
Background: Many lifestyle interventions for patients with prediabetes or type 2 diabetes mellitus (T2DM) have
been investigated in randomised clinical trial settings. However, the translation of these programmes into primary
care seems challenging and the prevalence of T2DM is increasing. Therefore, there is an urgent need for lifestyle
programmes, developed and shown to be effective in real-world primary care. We evaluated a lifestyle programme,
commissioned by the Dutch government, for patients with prediabetes or type 2 diabetes in primary care.
Methods: We performed a retrospective comparative medical records analysis using propensity score matching.
Patients with prediabetes or T2DM were selected from ten primary healthcare centres. Patients who received the
lifestyle intervention (n = 186) were compared with a matched group of patients who received usual care (n =
2632). Data were extracted from the electronic primary care records. Propensity score matching was used to
control for confounding by indication. Outcome measures were exercise level, BMI, HbA1c, fasting glucose, systolic
and diastolic blood pressure, total cholesterol, HDL and LDL cholesterol and triglycerides and the follow-up period
was one year.
Results: There was no significant difference at follow-up in any outcome measure between either group. The
reduction at one year follow-up of HbA1c and fasting glucose was positive in the intervention group compared
with controls, although not statistically significant (-0.12%, P = 0.07 and -0.17 mmol/l, P = 0.08 respectively).
Conclusions: The effects of the lifestyle programme in real-world primary care for patients with prediabetes or
T2DM were small and not statistically significant. The attention of governments for lifestyle interventions is
important, but from the available literature and the results of this study, it must be concluded that improving
lifestyle in real-world primary care is still challenging.
Background
Worldwide, an unhealthy lifestyle is one of the leading
causes of preventable death [1]. Inactive lifestyle and
obesity are highly associated with the risk of develop-
ing type 2 diabetes mellitus (T2DM) and the complica-
tions associated with this disease [2-5]. Many
programmes to improve physical activity and dietary
behaviour have been investigated. Randomised con-
trolled trials have shown positive effects of combined
lifestyle interventions on the development of T2DM in
patients with impaired glucose tolerance [6]. In
patients who already have T2DM, combined lifestyle
interventions improved weight loss, diabetes control
and cardiovascular risk factors [7]. However, the trans-
lation of these combined lifestyle interventions in com-
munity and primary care settings has been shown to
be promising, yet challenging [8-12]. In addition, the
effects of exercise-only programmes for patients with
T2DM were small, even in randomised trial settings
[13,14]. Furthermore, when investigated in primary
care, lifestyle counselling interventions had marginal
effects on cardiovascular risk [15], exercise-referral
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adults [16] and group education for patients with
T2DM had modest effects on weight loss and smoking
cessation [17].
Based on the positive results observed in randomised
trials and the change in emphasis that has taken place
in primary care from a curative setting into a setting
with an increasing focus on prevention, several countries
have adopted large scale lifestyle intervention pro-
grammes for patients with prediabetes (impaired fasting
glucose or impaired glucose tolerance) or T2DM in pri-
mary care. In the Netherlands, a nationwide programme
aimed at improving physical activity and dietary beha-
viour in patients with prediabetes or T2DM in primary
care was started in 2008, commissioned by the Dutch
Ministry of Health, Welfare and Sports (VWS) [18]. As
described above, lifestyle programmes in primary care
are challenging. Therefore, information about their real-
world effectiveness is crucial for healthcare providers,
researchers and policy makers [19,20]. The aim of our
study was to investigate the effectiveness of the Dutch
lifestyle programme for patients with diabetes or predia-
betes in real-world primary care setting, using regular
medical registration to evaluate the observed effects.
Methods
Setting and study design
We conducted this study in The Eindhoven Corporation
of Primary Health Care Centres (SGE), a corporation
comprising ten primary healthcare centres providing
care for approximately 60000 patients in the city of
Eindhoven, the Netherlands. SGE continuously registers
and stores data in the electronic primary care record,
which can be used for research purposes. We investi-
gated the differences between patients who participated
in a nationwide lifestyle programme and patients who
received usual care according to a diabetes management
programme. Within this programme, patients have regu-
lar checks annually with their GP and quarterly (three
times per year) with a diabetes practice nurse (DPN)
and if necessary in between. Every patient receives life-
style advice from the DPN. Patients go to a dietician for
a consultation on nutritional advice when they are diag-
nosed with the disease and if they start insulin therapy.
The DPN is trained in motivational interviewing.
We performed a retrospective comparative medical
records analysis using propensity score matching to con-
trol for confounding by indication. During the interven-
tion, neither healthcare providers nor patients were
aware that this study would be conducted.
The lifestyle programme
The Dutch Institute for Sports and Physical Activity
(NISB) developed and implemented a lifestyle
intervention programme for patients with (pre)diabetes
in primary care: the BeweegKuur [18]. The development
and implementation were funded by the Dutch Ministry
of Health, Welfare and Sports. The programme was gra-
dually implemented from 2008 in the Netherlands and
in 2012 it should be accessible everywhere in the Neth-
erlands. The programme was designed to be as prag-
matic as possible, meaning that it should fit within the
scope and possibilities of current usual care. To improve
implementation, the NISB provided additional training
for lifestyle coaches who supervised the programme.
The intervention will be reimbursed by Dutch health-
care insurance companies if it shows to be effective.
The primary goal of the BeweegKuur was to increase
physical activity and to improve dietary behaviour in
primary care patients with (a high risk for developing)
T2DM. Other goals were improvement of HbA1c, blood
pressure, BodyMassIndex (BMI), cholesterol, smoking
status, waist circumference and in the long-term preven-
tion of T2DM and lowering the incidence of complica-
tions. Patients were eligible to participate if they did not
meet the Dutch Standard for Healthy Physical Activity
(exercising at least half an hour for five or more days a
week) and were motivated to change their lifestyle.
Patients could not participate if they had T2DM with
three or more complications and/or with serious poly-
pharmacy (more than five different drug categories)
and/or with hypertension above 180/110 mmHg.
The intervention started with a referral to a lifestyle
coach, usually a DPN or physiotherapist. After this
referral, patients subsequently entered one of three dif-
ferent physical activity programmes and all patients had
one consultation with a dietician. The lifestyle coach
determined which of the three programmes was best
suited for the patient, coordinated the programme and
provided counselling for one year. Details of the inter-
vention have been published elsewhere [18].
Participants
SGE was one of the first organisations that participated
in the BeweegKuur. Four out of ten SGE-centres had
the possibility to participate in 2008. All patients with
prediabetes or T2DM who met the criteria for the inter-
vention could participate. Patients were invited during a
regular diabetes check-up or a regular consultation with
the GP.
For our analyses, we selected all patients with predia-
betes (fasting plasma glucose 6.1-6.9 mmol/l) and all
patients with T2DM (fasting plasma glucose > 6.9
mmol/l), registered with SGE on 1 January 2008, using
the (ICPC) codes B85.01 (prediabetes) and T90.02
(T2DM) [21] (Figure 1). Subsequently, we examined all
medical records of these patients to identify those who
participated in the intervention at some point in 2008.
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referred to and had at least one consultation with the
lifestyle coach. The control group consisted of all
patients with prediabetes or T2DM from all ten centres
of SGE who were not referred to the lifestyle coach.
The Medical Ethical Committee of the Maastricht
University Medical Centre has approved this study.
Outcome measures
As the intervention was designed to be part of usual
care, all data of the outcome measures were extracted
from the electronic primary care records. The outcome
measures for diabetes patients were routinely regis-
tered during quarterly check-ups with the GP or DPN
as part of the diabetes management programme and
patients with prediabetes had similar check-ups.
Therefore, data were collected for all patients with
(pre)diabetes, regardless of their participation in the
lifestyle programme. We extracted exercise level, BMI,
HbA1c, fasting glucose, systolic and diastolic blood
pressure, total cholesterol, HDL and LDL cholesterol
and triglycerides. Exercise level was also monitored by
the DPN during the regular quarterly check-ups. The
level could be recorded as 1: sedentary lifestyle, 2:
activities of daily living (e.g. grooming, dressing, eating)
3: healthy (exercising at least half an hour for five or
more days a week) or 4: sports (more active than level
3). Weight and blood pressure were measured by the
GP or DPN. Fasting glucose was measured in capillary
blood and HbA1c, cholesterol and triglyceride in
venous blood.
Statistical Analyses
Since data collection was part of usual care, it was not
possible to schedule follow-up measurements specific
for this research. Therefore, we calculated means of all
routinely recorded outcome measures for each patient
one year before and after the date in 2008 on which the
patient started the intervention. For the control group,
we calculated means of the outcome variables using
data of one year before and after 1 January 2008. In
addition we investigated the effects solely using data of
the last six months of the follow-up period of one year,
to account for a possible weak or strong effect in the
first six months. We only used those patients for ana-
lyses who had at least one measurement of the particu-
lar outcome measure in the year before and after the
individual starting date.
A priori differences in patient characteristics between
control group and intervention group may lead to biased
estimates. In order to decrease this bias, we used pro-
pensity score matching techniques [22]. The propensity
score of a person can be defined as the conditional
probability of being exposed to a treatment given the
person’s covariates. For every person in the control
g r o u pa n dt h ee x p e r i m e n t a lg r o u pap r o p e n s i t ys c o r e
was calculated. Using a logistic regression model we
estimated the propensity of participating in the interven-
tion for both intervention and control group based on a
set of observed covariates. Matching covariates included:
baseline score of specific outcome variables, age, gender,
socio-economic status (based on postal codes) [23], mar-
ital status, smoking, COPD, asthma, cancer, cardiovascu-
lar disease, hypertension, disorder of lipid metabolism,
cerebral ischemia, complaints of the locomotor system,
neurologic disease, depression and mental illness. All
these covariates were used to calculate the propensity
score of all individuals. Baseline matching covariates
were compared using independent t-test and chi-square
test (SPSS 17.0). Propensity scores were calculated using
Stata (version 10). All subjects in the control group
were matched to subjects in the intervention group
based on their propensity score, using a kernel matching
algorithm [24]. We used the t-test to calculate the dif-
ferences between both groups for all outcome variables.
As physical activity was measured on an ordinal level
and as we wanted to identify the changes in activity
rather than categorise the level, we used the t-test for
this variable as well.
Results
In total 186 patients with prediabetes (n = 28) or T2DM
(n = 158) participated in the BeweegKuur in 2008. The
Figure 1 Flowchart of study participants.
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started on December 16, 2008. The matching covariates
at study entry of both groups are shown in table 1. The
imbalances between intervention group and control
group at baseline as shown in table 1 endorse the need
for matching. On average, patients in the intervention
group were younger, were married more often and had
cardiovascular diseases or COPD less often. The base-
line outcome variables of study participants, as well as
the unadjusted and adjusted mean effects of the lifestyle
intervention are shown in tables 2 and 3.
Overall, we found no relevant changes in both the
intervention and control group. When using the propen-
sity score matching, it showed that there were no statis-
tically significant differences in effect between
intervention group and control group during one year
follow-up (table 2). There was a small positive, but not
statistically significant effect of the intervention on
HbA1c (-0.12%, CI = -0.30 to 0.06) compared with the
control group (Table 2). Similar results were found for
fasting glucose level (-0.17 mmol/l, CI = -0.38 to 0.04).
There were no differences in exercise level, BMI, fasting
glucose, blood pressure and cholesterol level between
either group. Exercise level showed a small decreasing
trend in both groups.
Similar results were found during the second half of
the one-year follow-up period (Table 3). There was no
significant difference in any outcome measure between
either group. The exercise level in the intervention
g r o u pw a sl o w e rc o m p a r e dw i t ht h ec o n t r o lg r o u p ,
although not statistically significant (p = 0.12). The posi-
tive trend of HbA1c observed during the first year was
also seen during the last six months of the intervention,
although with a higher p-value (p = 0.07 vs. p = 0.26).
During the last six months of the follow-up period
plasma triglyceride levels decreased, although not statis-
tically significant (-0.20 mmol/l, CI = -0.37 to 0.03).
Discussion
Summary of results
In the Netherlands, a nationwide lifestyle programme for
patients with prediabetes or T2DM was developed and
implemented. We evaluated this lifestyle programme in
real-world primary care. The effects of the programme
compared with usual care during one year follow-up
were small and not statistically significant or clinically
relevant.
Comparison with existing literature
Large randomised controlled trials of lifestyle pro-
grammes for patients with impaired glucose tolerance
have shown significant positive effects on various out-
come variables such as physical activity, HbA1c, weight,
glucose, blood pressure and serum lipids after one year
[25-27]. However, the results in our study follow a simi-
lar trend to the results in the Cochrane review by Tho-
mas et al [14]. This review investigated the effects of
exercise for type 2 diabetes mellitus and reported a
decrease in HbA1c of 0.6% and a slight lowering of
plasma triglycerides, but no other significant differences
were found. Our results on the exercise level in the last
six months of the intervention also resembles the find-
ings of a review by Williams et al. [16] about exercise-
referral schemes in primary care. These results showed
that referral schemes had a small effect on physical
activity, but that 17 patients needed to be referred for
one to become moderately active. Causes of this high
number needed to treat were poor rates of uptake and
adherence to the exercise schemes. This might have
happened in this lifestyle programme as well, despite
being a programme designed and implemented to result
in sustainable behaviour change [18]. Besides, our
results underline the conclusion of the review and meta-
analyses by Cardona-Morrell et al. [11], that showed
Table 1 Covariates of the study participants at baseline
used for matching
Characteristics Intervention
group
Control
group
P-
value
n 186 2632
Age (years) 62.93 ± 11.85 66.97 ± 12.56 0.00*
Sex male
Sex female
44.1%
55.9%
47.5%
52.5%
0.37
Socio-economic status ** 2.69 ± 0.79 2.75 ± 1.02 0.46
Married 59.7% 46.7% 0.00*
Diabetes mellitus type 2 † 84.9% 81.0% 0.18
Prediabetes † 15.1% 19.0% 0.18
Asthma † 5.9% 5.1% 0.64
Cancer † 12.9% 13.3% 0.88
Cardiovascular disease † 22.0% 32.0% 0.01*
Cerebral ischemia † 5.4% 9.0% 0.09
COPD † 1.1% 7.6% 0.00*
Depression † 9.1% 7.6% 0.45
Hypertension † 48.4% 50.6% 0.55
Locomotor system
complaints †
43.5% 37.7% 0.11
Lipid metabolism disorder † 26.3% 21.7% 0.14
Neurologic disorder † 7.5% 8.8% 0.55
Psychic disorder † 10.2% 8.4% 0.40
Smoking † 5.9% 5.1% 0.64
Data are means ± SD or frequencies (%).
* Groups differed significantly (P < 0.05).
** Socio-economic status based on postal code of patient on a scale of 1-4 (1
= -2 to -1 SD compared to total population of SGE, 2 = -1 to 0 SD compared
to total population, 3 = 0 to +1 SD compared to total population, 4 = +1 to
+2 SD compared to total population) [23].
† Based on ICPC-codes.
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mised trials into routine practice has less effect on dia-
betes risk reduction.
Up to now, the translation of results achieved in rando-
mised trials into routine clinical practice seems problematic
[11]. Various factors could explain why the effectiveness of
programmes seems to decrease when evaluated in real-
world settings. Different aspects could add up to the posi-
tive effect of an intervention in a trial setting, as explained
by Thorpe et al. [28] in their paper on differences between
explanatory and pragmatic trials. For example, explanatory
randomised clinical trials mainly use highly selected study
participants, excluding patients with possible lower chances
of a positive treatment effect. Besides, researchers and parti-
cipants in trials follow strict and often intensive protocols,
which could also lead to better adherence by the partici-
pants, but this might not be financially and practically feasi-
ble in real-world primary care.
Strengths and limitations of the study
The primary aim of our study was to investigate the effec-
tiveness of the intervention. Patients were analysed
Table 2 The effects of the lifestyle intervention compared with the control condition at one year follow-up
Outcome variables Means in
Intervention
group (SD)
Means in
Control
group (SD)
n Matched
Intervention†
Adjusted effect of
Intervention
(95% CI)‡
Adjusted
P-value
BMI (kg/m2) 152
Baseline 30.36 (4.93) 29.54 (5.08)
One year 30.33 (5.13) 29.63 (5.13) 0.04 (-0.87 to 0.94) 0.94
Exercise level (1-4)* 139
Baseline 2.48 (0.60) 2.48 (0.71)
One year 2.39 (0.73) 2.36 (0.71) -0.01 (-0.18 to 0.17) 0.89
Fasting glucose (mmol/l) 184
Baseline 7.21 (1.36) 7.28 (2.05)
One year 6.98 (1.20) 7.18 (1.50) -0.17 (-0.38 to 0.04) 0.08
HbA1c (%) 153
Baseline 6.73 (0.92) 6.66 (0.97)
One year 6.61 (0.75) 6.70 (0.87) -0.12 (-0.30 to 0.06) 0.07
Blood pressure
Systolic (mmHg) 176
Baseline 138.98 (16.64) 143.68 (17.41)
One year 138.59 (16.11) 142.90 (16.82) -1.49 (-4.19 to 1.21) 0.25
Diastolic (mmHg) 175
Baseline 79.88 (8.31) 79.39 (8.79)
One year 79.35 (7.82) 79.17 (8.64) -0.45 (-1.79 to 0.90) 0.48
Total cholesterol (mmol/l) 169
Baseline 4.54 (0.94) 4.56 (1.00)
One year 4.44 (1.00) 4.52 (0.98) -0.12 (-0.26 to 0.22) 0.83
LDL (mmol/l) 169
Baseline 2.80 (0.76) 2.85 (1.04)
One year 2.67 (0.84) 2.73 (0.83) 0.01 (-0.19 to 0.21) 0.91
HDL (mmol/l) 169
Baseline 1.16 (0.29) 1.16 (0.28)
One year 1.18 (0.30) 1.17 (0.31) 0.03 (-0.05 to 0.07) 0.68
Triglycerides (mmol/l) 169
Baseline 1.73 (0.98) 1.63 (0.95)
One year 1.79 (1.01) 1.69 (1.19) 0.03 (-0.21 to 0.26) 0.76
† Number of patients from the intervention group matched with patients in the control group.
‡ The adjusted effect of the intervention after the matching procedure.
* Exercise level: 1 = sedentary lifestyle; 2 = activities of daily living; 3 = exercising at least half an hour for five or more days a week (NNGB); 4 = more active
than NNGB.
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programme and at least one consultation with the lifestyle
coach) or usual care. We assumed that the effects after
this consultation with the lifestyle coach were inherent to
the intervention. In this study we had no data on treat-
ment adherence after the first consultation. Therefore, we
were unable to study whether poor treatment adherence
could be the reason for the lack of effectiveness.
Due to the non-randomised design of this study we
were not able to fully control for bias due to
confounding. We used propensity score matching to
overcome this problem. However, this does not take
into account possible unmeasured confounding. Motiva-
tion to exercise for example was not measured routinely,
so we could not control for this possible confounder. In
addition, we were not able to control for information
bias as a result of unblinded healthcare providers and
patients. However, one would expect that patients in the
intervention group were more motivated and that care-
givers and patients were inclined to be biased towards a
Table 3 The effects of the lifestyle intervention compared with the control condition at months 7-12 of follow-up
Outcome variables Means in
Intervention
group (SD)
Means in
Control
group (SD)
n Matched
Intervention†
Adjusted effect of
Intervention
(95% CI)‡
Adjusted
P-value
BMI (kg/m2) 134
Baseline 30.36 (4.93) 29.54 (5.08)
7-12 months 30.29 (5.08) 29.51 (5.18) 0.27 (-0.60 to 1.14) 0.56
Exercise level (1-4)* 107
Baseline 2.48 (0.60) 2.48 (0.71)
7-12 months 2.22 (0.86) 2.27 (0.81) -0.14 (-0.27 to 0.01) 0.12
Fasting glucose (mmol/l) 170
Baseline 7.21 (1.36) 7.28 (2.05)
7-12 months 7.07 (1.25) 7.17 (1.67) 0.08 (-0.11 to 0.26) 0.48
HbA1c (%) 94
Baseline 6.73 (0.92) 6.66 (0.97)
7-12 months 6.72 (0.83) 6.74 (0.90) -0.10 (-0.23 to 0.03) 0.26
Blood pressure
Systolic (mmHg) 166
Baseline 138.98 (16.64) 143.68 (17.41)
7-12 months 139.47 (16.55) 142.58 (17.47) -1.49 (-4.04 to 1.05) 0.73
Diastolic (mmHg) 165
Baseline 79.88 (8.31) 79.39 (8.79)
7-12 months 78.71 (8.18) 78.53 (9.20) -0.58 (-1.82 to 0.66) 0.40
Total cholesterol (mmol/l) 97
Baseline 4.54 (0.94) 4.56 (1.00)
7-12 months 4.56 (1.12) 4.52 (1.01) -0.02 (-0.18 to 0.14) 0.87
LDL (mmol/l) 97
Baseline 2.80 (0.76) 2.85 (1.04)
7-12 months 2.74 (0.92) 2.72 (0.85) 0.10 (-0.04 to 0.23) 0.34
HDL (mmol/l) 97
Baseline 1.16 (0.29) 1.16 (0.28)
7-12 months 1.18 (0.28) 1.18 (0.29) 0.00 (-0.05 to 0.05) 0.96
Triglycerides (mmol/l) 97
Baseline 1.73 (0.98) 1.63 (0.95)
7-12 months 1.83 (0.95) 1.76 (1.48) -0.20 (-0.37 to 0.03) 0.11
† Number of patients from the intervention group matched with patients in the control group. The numbers for this analysis are lower due to the fact that we
did not have the necessary data for all participants in this shorter time frame.
‡ The adjusted effect of the intervention after the matching procedure.
* Exercise level: 1 = sedentary lifestyle; 2 = activities of daily living; 3 = exercising at least half an hour for five or more days a week (NNGB); 4 = more active
than NNGB.
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intervention. Consequently, this would rather lead to
false positive results (bias from the null) than the
absence of positive results as shown in our data. On the
other hand, we cannot rule out bias to the null, for
example by not referring patients who are very little
motivated and who could benefit the most from the life-
style intervention. In addition, we only used data from
usual care electronic primary care records. However,
this would only be considered real information bias if
the quality or intensity of the registration depended on
treatment exposure, but considering the strict registra-
tion criteria within the diabetes management pro-
gramme, we assume this was not the case.
As regards the extrapolation of our findings beyond
our study population, we have to consider that we eval-
uated the nationwide lifestyle programme in only a sub-
set of healthcare centres, where we could be sure that
medical registration was adequate. The narrow 95% con-
fidence intervals indicate that we had sufficient statisti-
cal power. With a larger sample size some effects could
become statistically significant, but it is unlikely that
they will reach clinical relevance. The effects might be
related to specific organisational aspects of health care
centres. For example, it could be possible that the
selected health care centres were already very active in
lifestyle intervention, reducing the room for improve-
ment. On the other hand, diabetes care in The Nether-
lands is highly structured according to a nationwide GP-
guideline, so there should be no large differences in dia-
betes care.
Conclusions
Because real-world investigations and interventions are
necessary to really make a change in the diabetes epi-
demic, initiatives such as the BeweegKuur are very
important in primary healthcare. The attention of the
government for the increasing health and financial bur-
den of diabetes is promising and nationwide lifestyle
programmes are potentially relevant. On the other hand,
considering the currently available literature and the
results of our study, we should conclude that improving
lifestyle in real-world primary care is still challenging.
Qualitative research may be needed to find out how to
improve the programme and to know what is important
for patients and healthcare providers. Thorough process
evaluations might reveal the barriers and facilitators for
lifestyle intervention in diabetic patients in primary care.
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